Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001045013 | SCV001208840 | likely benign | Noonan syndrome 9 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004994202 | SCV005509529 | uncertain significance | Cardiovascular phenotype | 2024-11-14 | criteria provided, single submitter | clinical testing | The p.S271G variant (also known as c.811A>G), located in coding exon 6 of the SOS2 gene, results from an A to G substitution at nucleotide position 811. The serine at codon 271 is replaced by glycine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |